ArticleCancers2021

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial.

Thomas Geyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.